Response to âCorrespondence on âComparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry studyââ by Zheng et al
Pappas, Dimitrios A, St John, Gregory, Etzel, Carol J, Fiore, Stefano, Blachley, Taylor, Kimura, Toshio, Punekar, Rajeshwari, Emeanuru, Kelechi, Choi, Jeannie, Boklage, Susan, Kremer, Joel MJournal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2020-218907
Date:
November, 2020
File:
PDF, 170 KB
2020